A Stanford University investigation finds that its researchers did not take part in He Jiankui's work to develop gene-edited infants.
In Genome Biology this week: genomic sequencing of milkweed bug, benchmark comparison of single-cell RNA sequencing platforms, and more.
Researchers identified characteristic alterations, immune features, and interactions in hundreds of adenocarcinoma and squamous cell carcinomas from China.
Some of the mutational signatures the researchers observed were similar to ones previously seen in B cell tumors, underscoring the link between aging and cancer.
In PNAS this week: signals of natural selection among Indigenous populations of North America, population and social structures of several European Stone Age burial sites, and more.
The partners will offer Onegevity's GutBio assay, which integrates metagenomic sequencing with AI-based personalized recommendations to improve gut health, in Japan.
A Chinese study involving NIPS data from almost two million pregnant women found that a new bioinformatic approach improves the detection of cancer.
Stanford University's Stephen Quake tells the New York Times that he encouraged CRISPR researcher He Jiankui to seek the proper ethical approvals.
In PLOS this week: mutation rate differences between plant tissues, genomic analysis of Kerstersia gyiorum, and more.
The partners will work together on a US commercialization strategy for Genetic Technologies' line of existing and future polygenic risk tests.
The long-running Framingham Heart Study has received a $38 million grant, according to the Boston Globe.
Retraction Watch reports that two researchers had both a Science and a Nature paper retracted last week.